ori-image3
ori-image1
ori-image2

The future of Cell and Gene Therapy manufacturing just got brighter

Enter a new era of widespread access to lifesaving treatments

ori-image3
ori-image1
ori-image2

Enabling patient access to lifesaving treatmentsThat's our mission

With the revolutionary Ori manufacturing platform, it will be possible to increase throughput, improve quality and decrease costs in Cell and Gene Therapy (CGT) manufacturing, so that more patients can experience life's most precious moments with the people they love.

ori-hero-section3

Designed by experts with decades of Cell and Gene Therapy experience

Ori Biotech is a London- and New Jersey-based innovator in CGT manufacturing that has developed a proprietary, bespoke and flexible manufacturing platform, which enables patient access to a new generation of personalised, lifesaving treatments.

By fully automating and standardising CGT manufacturing in a closed platform, Ori offers therapeutics developers the opportunity to seamlessly scale from pre-clinical process development to commercial scale manufacturing.

So complex manufacturing challenges can be put where they belong – in the past.

Meet the team

Ori is pioneering the future of CGT manufacturing technology, bringing together the most innovative minds in the field who are truly passionate about helping to manufacture brighter futures.

  • Leadership
  • Board
  • Advisors
  • Farlan Veraitch, PhD

    Co-founder and Chief Scientific Officer

  • Jason C. Foster, MBA

    Chief Executive Officer and Executive Director

  • Jason Jones

    Chief Business Officer

  • William Raimes, PhD

    Head of Process Development

  • Arman Amini, PhD

    Head of Cell Processing

  • Andrew Gawman

    Global Finance Director

  • Thomas Heathman, PhD

    VP of Commercial Operations

  • Moeko Saito

    Scientific Project Manager

  • David Smith

    VP Technical Operations

Close

Farlan Veraitch, PhD

Co-founder and Chief Scientific Officer

Farlan is an internationally-recognised expert on CGT manufacturing, with over a decade of experience as a leading academic at University College London.

Our partners

Ori is building partnerships with the most forward-thinking organisations in the industry.

Latest News & Insights

Discover how we're driving innovation in CGT manufacturing.

Farlan Veraitch, Co-Founder and Chief Scientific Officer at Ori Biotech has been named as one of the 2021 PM360 ELITE 100

Read more

Learn more about the team working to enable patient access to lifesaving treatments

Read more

New article from The Medicine Maker: Ori Biotech CEO Jason C Foster discusses the impact of BREXIT on CGT manufacturing

themedicinemaker.com